A single tetracycline-regulated vector devised for controlled insulin gene expression

Chinese Medical Sciences Journal

Volumn 19, Issue 4, 2004, Pages 266-269

  Zhang, Xue Yang ^a   Su, Ben Li ^a   Li, Hong ^a   Bai, Ran ^a   Xu, Zhao Hui ^a   Li, Chang Chen ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Doxycycline; Insulin gene therapy; Tetracycline

Indexed keywords

CELL EXTRACT; DOXYCYCLINE; FURIN; IMMUNOREACTIVE INSULIN; INSULIN; MESSENGER RNA; PLASMID VECTOR; RECOMBINANT HUMAN INSULIN; TETRACYCLINE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN CYTOMEGALOVIRUS; INCUBATION TIME; INSULIN METABOLISM; MOUSE; MYOTUBE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXYCYCLINE; GENE EXPRESSION REGULATION; GENETIC VECTORS; INSULIN; MICE; MUSCLE FIBERS; PROINSULIN; RNA, MESSENGER; TRANSFECTION;

EID: 12344311506     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. The Diabetes Control and Complications Trial Research Group. The effects of intensive treatment of diabetes on the development and progression of long-term complication in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;325:837.
3. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: A progressive disease. Diabetes 1995;44:1249-58.
4. Lee HC, Kim SJ, Kim KS, et al. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue. Nature 2000;48:484-8.
5. Thule PM, Liu JM, Philips LS. Glucose regulated production of human insulin in rat hepatocytes. Gene Therapy 2000;7:205-14.
6. Chen R, Meseck M, McEvoy RC, et al. Glucose-stimulated and self-limiting insulin production by glucose 6-phosphatase promoter driven insulin expression in hepatoma cells. Gene Therapy 2000;7:1802-9.
7. Thule PM, Liu JM. Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Therapy 2000;7:1744-52.
8. MacColl GS, Goldspink G, Bouloux PM. Using skeletal muscle as an artificial endocrine tissue. J Endocrinol 1999;162:1-9.
9. Gossen M, Bujard H. Control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992;89:5547-51.
10. Rizzuto G, Cappelltti M, Maione D, et al. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc Natl Acad Sci USA 1999;96:6417-22.
11. Groskreutz DJ, Sliwkowaki MX, Gorman M. Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin. J Biol Chem 1994;269:6241-5.
12. Gros L, Riu E, Montoliu L, et al. Insulin production by engineered muscle cells. Hum Gene Therapy 1999;10:1207-17.
13. Baron U, Schnappinger D, Helbl V, et al. Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc Natl Acad Sci USA 1999;96:1013-8.
14. Liebert MA. "Tet-on": a gene switch for the exogenous regulation of transgene expression. Human Gene Therapy 1996;9:983-5.
15. Urlinger S, Baron U, Thellmann M, et al. Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci USA 2000;97:7963-8.
16. Zeng Q, Tan YH, Hong W. A single plasmid vector (pSTAR) mediating efficient tetracycline-induced gene therapy. Anal Biochem 1998;259:187-94.
17. Scougall KT, Maltin CA, Shaw JA. Tetracycline-regulated secretion of human insulin in a transfected non-endocrine cell line. J Mol Endocrinol 2003;30:331-46.